Desipramine and paroxetine showed a trend towards efficacy in treating depression in MS, but the trials assessing these antidepressants had a high number of patients lost to follow-up ( 254 ).
← all excerpts
Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review.
1
—
—